Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Mar;13(3):303–311. doi: 10.1111/j.1365-2125.1982.tb01379.x

Assessment of nephrotoxicity.

L F Prescott
PMCID: PMC1402111  PMID: 7037031

Full text

PDF
303

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BALAZS T., HATCH A., ZAWIDZKA Z., GRICE H. C. RENAL TESTS IN TOXICITY STUDIES ON RATS. Toxicol Appl Pharmacol. 1963 Sep;5:661–674. doi: 10.1016/0041-008x(63)90010-3. [DOI] [PubMed] [Google Scholar]
  2. BEN-ISHAY D. AMINOACIDURIA INDUCED BY SALICYLATES. J Lab Clin Med. 1964 Jun;63:924–932. [PubMed] [Google Scholar]
  3. Brown D. M., Hardy T. L. Short-term study of the effect of phenacetin, phenazone and amidopyrine on the rat kidney. Br J Pharmacol Chemother. 1968 Jan;32(1):17–24. doi: 10.1111/j.1476-5381.1968.tb00424.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bucht G., Wahlin A., Wentzel T., Winblad B. Renal function and morphology in long-term lithium and combined lithium-neuroleptic treatment. Acta Med Scand. 1980;208(5):381–385. doi: 10.1111/j.0954-6820.1980.tb01216.x. [DOI] [PubMed] [Google Scholar]
  5. Burry A., Cross R., Axelsen R. Analgesic nephropathy and the renal concentrating mechanism. Pathol Annu. 1977;12(Pt 2):1–31. [PubMed] [Google Scholar]
  6. Chantler C., Garnett E. S., Parsons V., Veall N. Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci. 1969 Aug;37(1):169–180. [PubMed] [Google Scholar]
  7. Coppen A., Bishop M. E., Bailey J. E., Cattell W. R., Price R. G. Renal function in lithium and non-lithium treated patients with affective disorders. Acta Psychiatr Scand. 1980 Oct;62(4):343–355. doi: 10.1111/j.1600-0447.1980.tb00620.x. [DOI] [PubMed] [Google Scholar]
  8. Curtis J. R., Donovan B. A. Assessment of renal concentrating ability. Br Med J. 1979 Feb 3;1(6159):304–305. doi: 10.1136/bmj.1.6159.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DAVIES D. F., SHOCK N. W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950 May;29(5):496–507. doi: 10.1172/JCI102286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. DE WARDENER H. E. Vasopressin tannate in oil and the urine concentration test. Lancet. 1956 Jun 30;270(6931):1037–1038. doi: 10.1016/s0140-6736(56)90801-7. [DOI] [PubMed] [Google Scholar]
  11. Davies D. J., Kennedy A. The excretion of renal cells following necrosis of the proximal convoluted tubule. Br J Exp Pathol. 1967 Feb;48(1):45–50. [PMC free article] [PubMed] [Google Scholar]
  12. Donker A. J., Arisz L., Brentjens J. R., van der Hem G. K., Hollemans H. J. The effect of indomethacin on kidney function and plasma renin activity in man. Nephron. 1976;17(4):288–296. doi: 10.1159/000180733. [DOI] [PubMed] [Google Scholar]
  13. Dossetor J. B. Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia. Ann Intern Med. 1966 Dec;65(6):1287–1299. doi: 10.7326/0003-4819-65-6-1287. [DOI] [PubMed] [Google Scholar]
  14. Dubach U. C., Jösch W. Urinenzyme nach medikamentöser Nierenreizung durch Salicylat. Schweiz Med Wochenschr. 1967 Oct 7;97(40):1314–1317. [PubMed] [Google Scholar]
  15. Ehrlich G. E., Wortham G. F. Pseudoproteinuria in tolmetin-treated patients. Clin Pharmacol Ther. 1975 Apr;17(4):467–468. doi: 10.1002/cpt1975174467. [DOI] [PubMed] [Google Scholar]
  16. Fredriksson A. Renal handling of beta2-microglobulin in experimental renal disease. Scand J Clin Lab Invest. 1975 Oct;35(6):591–600. doi: 10.1080/00365517509095785. [DOI] [PubMed] [Google Scholar]
  17. Galpin J. E., Shinaberger J. H., Stanley T. M., Blumenkrantz M. J., Bayer A. S., Friedman G. S., Montgomerie J. Z., Guze L. B., Coburn J. W., Glassock R. J. Acute interstitial nephritis due to methicillin. Am J Med. 1978 Nov;65(5):756–765. doi: 10.1016/0002-9343(78)90793-3. [DOI] [PubMed] [Google Scholar]
  18. Gent A. E., Taylor J. F., Brook C. G. Effect of frusemide, lactose, and urea on urinary cell loss. Br Med J. 1968 Nov 2;4(5626):294–296. doi: 10.1136/bmj.4.5626.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Goldring W., Chasis H., Ranges H. A., Smith H. W. RELATIONS OF EFFECTIVE RENAL BLOOD FLOW AND GLOMERULAR FILTRATION TO TUBULAR EXCRETORY MASS IN NORMAL MAN. J Clin Invest. 1940 Sep;19(5):739–750. doi: 10.1172/JCI101179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Harding S., Munro A. J. Frusemide and renal enzyme excretion. Br Med J. 1978 Nov 18;2(6149):1431–1431. doi: 10.1136/bmj.2.6149.1431-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hardy T. L. Identification of cells exfoliated from the rat kidney in experimental nephrotoxicity. Ann Rheum Dis. 1970 Jan;29(1):64–66. doi: 10.1136/ard.29.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hayes D. M., Cvitkovic E., Golbey R. B., Scheiner E., Helson L., Krakoff I. H. High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Cancer. 1977 Apr;39(4):1372–1381. doi: 10.1002/1097-0142(197704)39:4<1372::aid-cncr2820390404>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  23. Hoorntje S. J., Donker A. J., Prins E. J., Weening J. J. Membranous glomerulopathy in a patient on captopril. Acta Med Scand. 1980;208(4):325–329. doi: 10.1111/j.0954-6820.1980.tb01203.x. [DOI] [PubMed] [Google Scholar]
  24. Huvar A., Sitar J. Zmeny Hippuranové renografické krivky po fenylbutazonu Spofa. Vnitr Lek. 1971 Feb;17(2):147–153. [PubMed] [Google Scholar]
  25. Jösch W., Dubach U. C., Strobel M. Der Einfluss des Urin-pH auf die Aktivität von Urinenzymen. Experientia. 1967 May 15;23(5):342–343. doi: 10.1007/BF02144504. [DOI] [PubMed] [Google Scholar]
  26. Kalkay N. M. Polyuric renal failure and hepatitis: associated with methoxyflurane anesthesia. N Y State J Med. 1977 Dec;77(14):2265–2269. [PubMed] [Google Scholar]
  27. Kampmann J. P., Hansen J. M. Glomerular filtration rate and creatinine clearance. Br J Clin Pharmacol. 1981 Jul;12(1):7–14. doi: 10.1111/j.1365-2125.1981.tb01848.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kimberly R. P., Bowden R. E., Keiser H. R., Plotz P. H. Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med. 1978 May;64(5):804–807. doi: 10.1016/0002-9343(78)90520-x. [DOI] [PubMed] [Google Scholar]
  29. Kunin C. M., Chesney R. W., Craig W. A., England A. C., DeAngelis C. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease. Pediatrics. 1978 Nov;62(5):751–760. [PubMed] [Google Scholar]
  30. Leathwood P. D., Plummer D. T. The excretion of lacate dehydrogenase in human urine after he ingestion of aspiin. Biochem J. 1969 Sep;114(2):197–202. doi: 10.1042/bj1140197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lee M. R. Effects of drugs on water metabolism. Br J Clin Pharmacol. 1981 Sep;12(3):289–293. doi: 10.1111/j.1365-2125.1981.tb01216.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lindvall N. Radiological changes of renal papillary necrosis. Kidney Int. 1978 Jan;13(1):93–106. doi: 10.1038/ki.1978.12. [DOI] [PubMed] [Google Scholar]
  33. Magos L., Tandon S. K. Decreased nephrotoxic effect of mercuric chloride on the regenerating kidneys [proceedings]. Br J Pharmacol. 1979 Jul;66(3):437P–438P. [PMC free article] [PubMed] [Google Scholar]
  34. Mitchell J. R., McMurtry R. J., Statham C. N., Nelson S. D. Molecular basis for several drug-induced nephropathies. Am J Med. 1977 Apr;62(4):518–526. doi: 10.1016/0002-9343(77)90407-7. [DOI] [PubMed] [Google Scholar]
  35. Mondorf A. W., Breier J., Hendus J., Scherberich J. E., Mackenrodt G., Shah P. M., Stille W., Schoeppe W. Effect of aminoglycosides on proximal tubular membranes of the human kidney. Eur J Clin Pharmacol. 1978 May 17;13(2):133–142. doi: 10.1007/BF00609758. [DOI] [PubMed] [Google Scholar]
  36. Nanra R. S., Kincaid-Smith P. Chronic effect of analgesics on the kidney. Prog Biochem Pharmacol. 1972;7:285–323. [PubMed] [Google Scholar]
  37. Olivero J. J., Lozano-Mendez J., Ghafary E. M., Eknoyan G., Suki W. N. Mitigation of amphotericin B nephrotoxicity by mannitol. Br Med J. 1975 Mar 8;1(5957):550–551. doi: 10.1136/bmj.1.5957.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ono T., Eto K., Arakawa K. Origin of urinary enzymes hydrolysing beta-naphthylamides of L-leucine and L-glutamic acid. Clin Chim Acta. 1968 Feb;19(2):257–265. doi: 10.1016/0009-8981(68)90334-3. [DOI] [PubMed] [Google Scholar]
  39. Pesce A. J., Hanenson I., Sethi K. beta2 microglobulinuria in a patient with nephrotoxicity secondary to mercuric chloride ingestion. Clin Toxicol. 1977;11(3):309–315. doi: 10.3109/15563657708989845. [DOI] [PubMed] [Google Scholar]
  40. Peterson P. A., Evrin P. E., Berggård I. Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein. J Clin Invest. 1969 Jul;48(7):1189–1198. doi: 10.1172/JCI106083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Price R. G., Dance N., Richards B., Cattell W. R. The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase following surgery to the kidney. Clin Chim Acta. 1970 Jan;27(1):65–72. doi: 10.1016/0009-8981(70)90375-x. [DOI] [PubMed] [Google Scholar]
  42. Proctor R. A., Kunin C. M. Salicylate-induced enzymuria: comparison with other anti-inflammatory agents. Am J Med. 1978 Dec;65(6):987–993. doi: 10.1016/0002-9343(78)90751-9. [DOI] [PubMed] [Google Scholar]
  43. Raab W. P. Acetylsalicylic acid and the kidneys. Helv Med Acta. 1969 Mar;34(6):498–502. [PubMed] [Google Scholar]
  44. Raab W. P. Diagnostic value of urinary enzyme determinations. Clin Chem. 1972 Jan;18(1):5–25. [PubMed] [Google Scholar]
  45. Rowe J. W., Andres R., Tobin J. D., Norris A. H., Shock N. W. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 1976 Mar;31(2):155–163. doi: 10.1093/geronj/31.2.155. [DOI] [PubMed] [Google Scholar]
  46. Russell G. I., Bing R. F., Walls J., Pettigrew N. M. Interstitial nephritis in a case of phenylbutazone hypersensitivity. Br Med J. 1978 May 20;1(6123):1322–1322. doi: 10.1136/bmj.1.6123.1322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. SCOTT J. T., DENMAN A. M., DORLING J. Renal irritation caused by salicylates. Lancet. 1963 Feb 16;1(7277):344–348. doi: 10.1016/s0140-6736(63)91379-5. [DOI] [PubMed] [Google Scholar]
  48. Schardijn G., Statius van Eps L. W., Swaak A. J., Kager J. C., Persijn J. P. Urinary beta 2 microglobulin in upper and lower urinary-tract infections. Lancet. 1979 Apr 14;1(8120):805–807. doi: 10.1016/s0140-6736(79)91320-5. [DOI] [PubMed] [Google Scholar]
  49. Schentag J. J., Cumbo T. J., Jusko W. J., Plaut M. E. Gentamicin tissue accumulation and nephrotoxic reactions. JAMA. 1978 Nov 3;240(19):2067–2069. [PubMed] [Google Scholar]
  50. Smith H. W., Finkelstein N., Aliminosa L., Crawford B., Graber M. THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. J Clin Invest. 1945 May;24(3):388–404. doi: 10.1172/JCI101618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Smith H. W., Goldring W., Chasis H. THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEY. J Clin Invest. 1938 May;17(3):263–278. doi: 10.1172/JCI100950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Steele T. W., Györy A. Z., Edwards K. D. Renal function in analgesic nephropathy. Br Med J. 1969 Apr 26;2(5651):213–216. doi: 10.1136/bmj.2.5651.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Stroo W. E., Hook J. B. Enzymes of renal origin in urine as indicators of nephrotoxicity. Toxicol Appl Pharmacol. 1977 Mar;39(3):423–434. doi: 10.1016/0041-008x(77)90135-1. [DOI] [PubMed] [Google Scholar]
  54. WRONG O., DAVIES H. E. The excretion of acid in renal disease. Q J Med. 1959 Apr;28(110):259–313. [PubMed] [Google Scholar]
  55. Wellwood J. M., Lovell D., Thompson A. E., Tighe J. R. Renal damage caused by gentamicin: a study of the effects on renal morphology and urinary enzyme excretion. J Pathol. 1976 Mar;118(3):171–182. doi: 10.1002/path.1711180307. [DOI] [PubMed] [Google Scholar]
  56. Wellwood J. M., Simpson P. M., Tighe J. R., Thompson A. E. Evidence of gentamicin nephrotoxicity in patients with renal allografts. Br Med J. 1975 Aug 2;3(5978):278–281. doi: 10.1136/bmj.3.5978.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wright P. J., Plummer D. T. The use of urinary enzyme measurements to detect renal damage caused by nephrotoxic compounds. Biochem Pharmacol. 1974 Jan 1;23(1):65–73. doi: 10.1016/0006-2952(74)90314-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES